We interviewed Professor Walter Atwood last week at the 2018 ECTRIMS congress in Berlin, Germany, to learn about advances in treating progressive multifocal leukoencephalopathy (PML) – an important treatment-associated infection in patients with multiple sclerosis (MS). Watch the interview to listen to Professor Atwood’s insights into new ways to tackle the risks of PML, including anti-viral treatments.
Want to learn more about PML and other treatment-associated side-effects in MS? Read our previous articles here and here, and have a look at Professor Atwood’s recent research on the causative virus in PML.
Walter Atwood is a Professor of Medical Science, Director of Cancer Signaling, and Vice Chair of Molecular Biology, Cell Biology and Biochemistry at Brown University (Providence, Rhode Island, USA).